
AstraZeneca withdraws COVID vaccine worldwide due to TTS. Facing 100 million pound lawsuit. TTS involves blood clots, low platelets. Symptoms: severe headache, abdominal pain. Treatment: anticoagulant therapy. The vaccine, developed by AstraZeneca and Oxford University, was produced by the Serum Institute of India as Covishield. Read the article to know more.